Cipla informs about press release

07 Jul 2023 Evaluate

Cipla has informed that it enclosed press release dated 7th July 2023 titled ‘Voluntary nationwide recall of six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to container defect by Cipla USA Inc., wholly owned step down subsidiary of the Company in USA’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1326.30 0.20 (0.02%)
24-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1730.55
Dr. Reddys Lab 1299.40
Cipla 1326.30
Zydus Lifesciences 904.35
Lupin 2251.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×